NCT06209606 2024-12-17Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple MyelomaOncotherapeuticsPhase EARLY_PHASE1 Recruiting30 enrolled
NCT01537861 2015-01-26Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple MyelomaWashington University School of MedicinePhase EARLY_PHASE1 Terminated7 enrolled